Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.
Open | $41.70 |
Close | $41.68 |
Volume / Avg. | 698.05K / 973.21K |
Day Range | $40.80 - $41.85 |
52 Wk Range | 13.72 - 42.67 |
Market Cap | $2.43B |
P/E Ratio | 15.24 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 5% |
Days to Cover | 4.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Other companies in Protagonist Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Protagonist Therapeutics has a consensus price target of $46.70.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $41.25 last updated August 23, 2024 at 5:16 PM EDT.
There are no upcoming dividends for Protagonist Therapeutics.
Protagonist Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.